Integrated Protein Technologies, Inc. is proud to announce that it has been awarded a Phase I STTR, in collaboration with Northwestern University, to develop new technologies for the rapid analysis of current and next-generation biotherapeutics.

The National Institutes of Health have awarded Integrated Protein Technologies with a Phase I SBIR to develop technology aimed at significantly reducing the per sample analysis cost associated with proteomics based methods.  Ultimately, we hope this technology will lead to the commoditization of protein measurement and enable its use in a wide variety of applications including basic research, food safety, biologic development and more.

A Better Way To Do Proteomics

Integrated Protein Technologies, Inc. offers investors an opportunity to partner in creating the technologies that will commoditize advanced protein measurements, enabling the application of this technology in important areas like pharmaceutical development and medical diagnostics.

Learn More